Weizmann Institute scientists report why taste and smell differ among individuals

"De gustibus non est disputandum" is a popular saying, conveying that one shouldn't argue about flavors. Now, a team at the Weizmann Institute of Science, headed by Prof. Doron Lancet of the Molecular Genetics Department, has found why this is true.

In our genome, around 1,000 genes code for the nose's odor-detecting receptors (responsible for our sense of smell and a great part of flavor perception). Of these, more than half have become totally inactive in all humans, a fact that has been known for years. Now a surprising discovery, published in Nature Genetics, shows that at least 50 genes are "optional" they can be active in some individuals and inactive in others. This high level of genetic variation among individuals is most unusual.

A simple calculation, based on the new findings, shows that nearly every human being would display a different pattern of active/inactive receptors an individualized genetic barcode. The uncovered genetic heterogeneity affects the way thousands of aromas and flavors are perceived.

Furthermore, the new research shows that the level of obliteration of olfactory receptors varies among different ethnic groups.

The novel discovery has profound implications for the way the perfume, food and beverage industries handle the discovery of new aroma, flavor and fragrance ingredients. Usually one person, or a small test panel, makes sensory decisions taken to represent billions of customers. But since every nose is different, industry might rethink such issues. The investigators believe that soon a DNA chip could be used to perform olfactory genetics typing of panels and target audiences alike. Thus, cosmetics and foodstuff design would be revolutionized in much the same way that the drug industry now seriously contemplates developing tailor-made medications based on the breakthroughs of pharmacogenetics.


Contact: Alex Smith
American Committee for the Weizmann Institute of Science

Page: 1

Related biology news :

1. Weizmann scientists invention moves forward: Cancer diagnosis technique gets FDA clearance
2. Psoriasis treatment based on Weizmann Institute Research passes phase II clinical trials
3. Weizmann Institute scienists find that stem cells in the bone marrow become liver cells
4. Weizmann institute scientists solve the 3-D structure of the enzyme involved in Gaucher disease
5. Prize to Weizmann Institute professor for landmark work in stem cell transplantation
6. New witchweed-fighting method, presented by CIMMYT and Weizmann Institute scientist
7. Weizmann Institute scientists win global competition in predicting protein-protein interactions
8. Vaccination following spinal cord injury: Innovative Weizmann Institute approach limits paralysis
9. Weizmann Institute scientists block loss of eyesight in animals with a glaucoma-like disease
10. Weizmann Institute researcher named to Israel Academy Of Sciences And Humanities
11. Weizmann Institute scientists develop a novel system for analyzing genetic data that mimics the human capacity for unsupervised learning

Post Your Comments:

(Date:6/19/2020)... ... June 18, 2020 , ... ... series, “Automate Your Lab with Software for Data Decisions,” for pharmaceutical and ... how to integrate and automate cutting-edge scientific instruments and laboratory equipment from ...
(Date:6/5/2020)... MURRIETA, Calif. (PRWEB) , ... June 04, 2020 , ... ... , has filed a new patent application for simplified sample preparation for Next ... technology that will greatly reduce cost, time, and complexity of sample preparation. , “I ...
(Date:5/28/2020)... ... 27, 2020 , ... CrucialTrak, a global designer and manufacturer of biometric access ... (CEG) to market and sell its complete line of biometric readers and access ... infrastructure optimization solutions . , Brett Mason, CrucialTrak’s Director of Channel Sales for ...
Breaking Biology News(10 mins):
(Date:8/7/2020)... ... August 06, 2020 , ... VGXI, a highly ... closed on the purchase of greenfield for a new, expanded manufacturing facility. The ... 21 acres in the initial acquisition, with an option to purchase an additional ...
(Date:8/3/2020)... , ... August 03, 2020 , ... ... today announced Jim Corrigan, President and CEO has been named one of the ... cross-section of industry sectors, PharmaVoice 100 honorees are selected based on how they ...
(Date:8/3/2020)... ... 2020 , ... Introducing Ardent Animal Health – MediVet Biologics rebrands company and ... Known as MediVet Biologics since its formation in 2016, the company is relaunching itself ... will build on its base of innovative therapies for osteoarthritis and cancer. ...
(Date:7/31/2020)... ... ... R3 Stem Cell International is now offering patients the opportunity to receive four ... may choose which extremities they would like treated. , Several studies have shown just ... R3 International, umbilical cord tissue is obtained from a lab with a long history ...
Breaking Biology Technology:
Cached News: